Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
DUNCAN BARBARA GAYLEDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074985 · ownership.xml · derivative · entry 2 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units are fully vested. F3 · derivative.expiration_date: The restricted stock units do not have an expiration date. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
DUNCAN BARBARA GAYLEDirector
|
Exercise / conversionCommon Stock | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074985 · ownership.xml · nonDerivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
BERGER FRANKLIN MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074987 · ownership.xml · derivative · entry 2 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units are fully vested. F3 · derivative.expiration_date: The restricted stock units do not have an expiration date. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
BERGER FRANKLIN MDirector
|
Exercise / conversionCommon Stock | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074987 · ownership.xml · nonDerivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 811,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
Murphy Polly A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074989 · ownership.xml · derivative · entry 2 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock unites are fully vested. F3 · derivative.expiration_date: The restricted stock units do not have an expiration date. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
Murphy Polly A.Director
|
Exercise / conversionCommon Stock | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074989 · ownership.xml · nonDerivative · entry 1 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
Lucidi BrunoDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074988 · ownership.xml · derivative · entry 2 Lucidi Bruno · CIK 0001829622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units are fully vested. F3 · derivative.expiration_date: The restricted stock units do not have an expiration date. Read SEC document |
| June 16, 2024 Filed Jun 18, 2024 21:00 UTC |
Lucidi BrunoDirector
|
Exercise / conversionCommon Stock | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074988 · ownership.xml · nonDerivative · entry 1 Lucidi Bruno · CIK 0001829622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 18:34 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
SaleCommon Stock | 1,006 | $4.00 | $4,024.00 |
DisclosureSEC source: 0000950170-24-070965 · ownership.xml · nonDerivative · entry 1 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Plan reported Ownership: Indirect · Held by JPM Partners LLC Disclosed balance after: 5,923,994 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:26 UTC |
Foster WayneEVP, Chief Accounting Officer
|
SaleCommon Stock | 12,477 | $3.84 | $47,904.19 |
DisclosureSEC source: 0000950170-24-010969 · ownership.xml · nonDerivative · entry 2 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,857 F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 15, 2022. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:30 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
SaleCommon Stock | 56,910 | $3.85 | $218,818.95 |
DisclosureSEC source: 0000950170-24-010972 · ownership.xml · nonDerivative · entry 2 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,557 F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated May 18, 2023. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:31 UTC |
Corcoran AndreaSee Remarks
|
SaleCommon Stock | 15,843 | $3.84 | $60,914.75 |
DisclosureSEC source: 0000950170-24-010973 · ownership.xml · nonDerivative · entry 2 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 670,208 F3 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022. Read SEC document |
| February 01, 2024 Filed Feb 3, 2024 02:29 UTC |
Horga Maria ArantxaChief Medical Officer
|
SaleCommon Stock | 15,870 | $3.84 | $60,963.02 |
DisclosureSEC source: 0000950170-24-010970 · ownership.xml · nonDerivative · entry 2 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,664 F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022. Read SEC document |
| February 01, 2024 Filed Feb 3, 2024 02:25 UTC |
Vavricka JohnChief Commercial Officer
|
SaleCommon Stock | 11,819 | $3.84 | $45,420.42 |
DisclosureSEC source: 0000950170-24-010968 · ownership.xml · nonDerivative · entry 2 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,515 F2 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 25, 2022. Read SEC document |
| February 01, 2024 Filed Feb 3, 2024 02:24 UTC |
Hammond Janet MJChief Development Officer
|
SaleCommon Stock | 14,029 | $3.84 | $53,913.45 |
DisclosureSEC source: 0000950170-24-010967 · ownership.xml · nonDerivative · entry 2 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,362 F3 · shares: Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:26 UTC |
Foster WayneEVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,100 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000950170-24-010969 · ownership.xml · derivative · entry 4 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,100 Underlying: Common Stock · 120,100 shares Expires 2034-01-30 F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:26 UTC |
Foster WayneEVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 33,334 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010969 · ownership.xml · derivative · entry 3 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,666 Underlying: Common Stock · 33,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. F3 · derivative.expiration_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:26 UTC |
Foster WayneEVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 33,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010969 · ownership.xml · nonDerivative · entry 1 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 448,000 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000950170-24-010972 · ownership.xml · derivative · entry 5 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 448,000 Underlying: Common Stock · 448,000 shares Expires 2034-01-30 F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
Exercise / conversionRestricted Stock Units · Derivative | 173,467 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010972 · ownership.xml · derivative · entry 4 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,933 Underlying: Common Stock · 173,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The original grant of 520,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. F3 · derivative.expiration_date: The original grant of 520,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:30 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
Exercise / conversionCommon Stock | 173,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010972 · ownership.xml · nonDerivative · entry 1 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:31 UTC |
Corcoran AndreaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000950170-24-010973 · ownership.xml · derivative · entry 4 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-01-30 F5 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:31 UTC |
Corcoran AndreaSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 44,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010973 · ownership.xml · derivative · entry 3 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,733 Underlying: Common Stock · 44,367 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. F4 · derivative.expiration_date: The original grant of 133,100 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:31 UTC |
Corcoran AndreaSee Remarks
|
Exercise / conversionCommon Stock | 44,367 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010973 · ownership.xml · nonDerivative · entry 1 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,051 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 8,680 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:29 UTC |
Horga Maria ArantxaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 192,800 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000950170-24-010970 · ownership.xml · derivative · entry 4 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,800 Underlying: Common Stock · 192,800 shares Expires 2034-01-30 F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:29 UTC |
Horga Maria ArantxaChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 41,534 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010970 · ownership.xml · derivative · entry 3 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,066 Underlying: Common Stock · 41,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The original grant of 124,600 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. F3 · derivative.expiration_date: The original grant of 124,600 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:29 UTC |
Horga Maria ArantxaChief Medical Officer
|
Exercise / conversionCommon Stock | 41,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010970 · ownership.xml · nonDerivative · entry 1 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:25 UTC |
Vavricka JohnChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 132,800 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000950170-24-010968 · ownership.xml · derivative · entry 5 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,800 Underlying: Common Stock · 132,800 shares Expires 2034-01-30 F4 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:25 UTC |
Vavricka JohnChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 33,334 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010968 · ownership.xml · derivative · entry 4 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,666 Underlying: Common Stock · 33,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. F3 · derivative.expiration_date: The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:25 UTC |
Vavricka JohnChief Commercial Officer
|
Exercise / conversionCommon Stock | 33,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010968 · ownership.xml · nonDerivative · entry 1 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:24 UTC |
Hammond Janet MJChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 225,200 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000950170-24-010967 · ownership.xml · derivative · entry 4 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,200 Underlying: Common Stock · 225,200 shares Expires 2034-01-30 F5 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:24 UTC |
Hammond Janet MJChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 46,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010967 · ownership.xml · derivative · entry 3 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,600 Underlying: Common Stock · 46,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. F4 · derivative.expiration_date: The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:24 UTC |
Hammond Janet MJChief Development Officer
|
Exercise / conversionCommon Stock | 46,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010967 · ownership.xml · nonDerivative · entry 1 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 2,591 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Adams Jerome M.Director
|
GrantStock Option (Right to Buy) · Derivative | 46,750 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-23-016130 · doc4.xml · derivative · entry 2 Adams Jerome M. · CIK 0001863366 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 Underlying: Common Stock · 46,750 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Adams Jerome M.Director
|
GrantRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016130 · doc4.xml · derivative · entry 1 Adams Jerome M. · CIK 0001863366 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Polsky BruceDirector
|
GrantStock Option (Right to Buy) · Derivative | 46,750 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-23-016128 · doc4.xml · derivative · entry 2 Polsky Bruce · CIK 0001508458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 Underlying: Common Stock · 46,750 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Polsky BruceDirector
|
GrantRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016128 · doc4.xml · derivative · entry 1 Polsky Bruce · CIK 0001508458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 46,750 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-23-016127 · doc4.xml · derivative · entry 2 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 Underlying: Common Stock · 46,750 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016127 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
BERGER FRANKLIN MDirector
|
GrantStock Option (Right to Buy) · Derivative | 46,750 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-23-016131 · doc4.xml · derivative · entry 2 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 Underlying: Common Stock · 46,750 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
BERGER FRANKLIN MDirector
|
GrantRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016131 · doc4.xml · derivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Murphy Polly A.Director
|
GrantStock Option (Right to Buy) · Derivative | 46,750 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-23-016129 · doc4.xml · derivative · entry 2 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 Underlying: Common Stock · 46,750 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Murphy Polly A.Director
|
GrantRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016129 · doc4.xml · derivative · entry 1 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Lucidi BrunoDirector
|
GrantStock Option (Right to Buy) · Derivative | 46,750 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-23-016126 · doc4.xml · derivative · entry 2 Lucidi Bruno · CIK 0001829622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 Underlying: Common Stock · 46,750 shares Expires 2033-06-15 F3 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 16, 2023, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:05 UTC |
Lucidi BrunoDirector
|
GrantRestricted Stock Units · Derivative | 33,150 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-016126 · doc4.xml · derivative · entry 1 Lucidi Bruno · CIK 0001829622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,150 Underlying: Common Stock · 33,150 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. F2 · derivative.expiration_date: The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:38 UTC |
Foster WayneEVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000899243-23-003629 · doc4.xml · derivative · entry 2 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2033-01-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:38 UTC |
Foster WayneEVP, Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003629 · doc4.xml · derivative · entry 1 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:33 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 728,600 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000899243-23-003615 · doc4.xml · derivative · entry 2 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728,600 Underlying: Common Stock · 728,600 shares Expires 2033-01-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:33 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
GrantRestricted Stock Units · Derivative | 520,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003615 · doc4.xml · derivative · entry 1 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,400 Underlying: Common Stock · 520,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:30 UTC |
Corcoran AndreaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 186,300 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000899243-23-003607 · doc4.xml · derivative · entry 2 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,300 Underlying: Common Stock · 186,300 shares Expires 2033-01-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.